MaxCyte | Investor Presentation Deck | 19 slides

MaxCyte · 2023-10
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

19
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
The slide uses a three-column layout to summarize key value propositions.summarize
04
The slide uses a dual-track timeline showing the progression of Cell Therapy and Drug Discovery business segments alongside corporate milestones.establish_context
05
The slide uses a process flow diagram to show the funnel from potential partnerships to active clinical programs.show_traction
Open slide detailBeat · Traction
06
The chart shows a cumulative growth of partnerships over time from 2017 to 2023.show_traction
Open slide detailBeat · Traction
07
Includes a mix of historical data, pipeline metrics, and future projections.size_opportunity
Open slide detailBeat · ProblemLoop · Cost Of Inaction
08
Uses a before-after-bridge style framing to contrast pain points with platform capabilities.present_solution
Open slide detailBeat · ProblemLoop · Cost Of Inaction
09
The slide highlights the transition from RUO to cGMP capabilities across the product line.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
10
The slide explicitly labels the model as 'Razor/Razor Blade Economics'.present_solution
Open slide detailBeat · Business Model
11
Uses the 'Razor/Razor Blade' business model framework.present_solution
Open slide detailBeat · Business Model
12
The chart uses a timeline-based progression from early clinical to commercial phase.analyze_data
13
The chart uses a stacked bar format to distinguish between pre-commercial and commercial revenue components.analyze_data
14
The slide uses donut charts to visualize the distribution of milestone events across IND, Pre-Pivotal, and Pivotal or Later phases.show_traction
15
The slide uses a wave-based visual metaphor to represent sequential growth phases.plan_implementation
16
The diagram uses concentric circles to represent clinical phases and color-coded dots to represent cell approaches (allogeneic vs autologous).show_traction
17
The slide uses a Vitruvian Man-style graphic to represent the breadth of therapeutic applications.show_traction
18
The slide uses a process diagram to anchor the business updates.summarize
Open slide detailLoop · Why Now
19
state_next_steps
Open slide detailLoop · Why Now